3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
21
Recurrence
3
Neoplasms, Plasma Cell
2
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
HIV Infections
1
Anemia, Sickle Cell
1
Interventions
fludarabine
9
Cyclophosphamide
8
fludarabine phosphate
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Whole-Body Irradiation
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
CPX-351
4
X-Rays
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Bortezomib
×
30 days
×
Clear all
No trials found.